Aimmune Therapeutics Stock Fundamentals
Aimmune Therapeutics fundamentals help investors to digest information that contributes to Aimmune Therapeutics' financial success or failures. It also enables traders to predict the movement of Aimmune Stock. The fundamental analysis module provides a way to measure Aimmune Therapeutics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Aimmune Therapeutics stock.
Aimmune |
Aimmune Therapeutics Company Shares Owned By Insiders Analysis
Aimmune Therapeutics' Shares Owned by Insiders show the percentage of outstanding shares owned by insiders (such as principal officers or members of the board of directors) or private individuals and entities with over 5% of the total shares outstanding. Company executives or private individuals with access to insider information share information about a firm's operations that is not available to the general public.
More About Shares Owned By Insiders | All Equity Analysis
Insiders Shares | = | Executives Shares | + | Employees |
Current Aimmune Therapeutics Shares Owned By Insiders | 20.86 % |
Most of Aimmune Therapeutics' fundamental indicators, such as Shares Owned By Insiders, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Aimmune Therapeutics is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Although the research on effects of insider trading on prices and volatility is still relatively inconclusive, and investors are advised to pay close attention to the distribution of equities among company's stakeholders to avoid many problems associated with the disclosure of price-sensitive information.
CompetitionBased on the latest financial disclosure, 20.86% of Aimmune Therapeutics are shares owned by insiders. This is 37.42% higher than that of the Healthcare sector and 47.11% higher than that of the Biotechnology industry. The shares owned by insiders for all United States stocks is 106.74% lower than that of the firm.
Aimmune Therapeutics Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Aimmune Therapeutics's current stock value. Our valuation model uses many indicators to compare Aimmune Therapeutics value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Aimmune Therapeutics competition to find correlations between indicators driving Aimmune Therapeutics's intrinsic value. More Info.Aimmune Therapeutics is number one stock in return on equity category among related companies. It is number one stock in return on asset category among related companies . Comparative valuation analysis is a catch-all model that can be used if you cannot value Aimmune Therapeutics by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Aimmune Therapeutics' Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Aimmune Therapeutics' earnings, one of the primary drivers of an investment's value.Aimmune Shares Owned By Insiders Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Aimmune Therapeutics' direct or indirect competition against its Shares Owned By Insiders to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Aimmune Therapeutics could also be used in its relative valuation, which is a method of valuing Aimmune Therapeutics by comparing valuation metrics of similar companies.Aimmune Therapeutics is currently under evaluation in shares owned by insiders category among related companies.
Aimmune Fundamentals
| Return On Equity | -149.17 | |||
| Return On Asset | -53.24 | |||
| Current Valuation | 2.09 B | |||
| Shares Outstanding | 65.45 M | |||
| Shares Owned By Insiders | 20.86 % | |||
| Shares Owned By Institutions | 82.85 % | |||
| Number Of Shares Shorted | 4.18 M | |||
| Price To Earning | (13.68) X | |||
| Price To Book | 12.55 X | |||
| Revenue | 575 K | |||
| EBITDA | (277.79 M) | |||
| Net Income | (287.03 M) | |||
| Cash And Equivalents | 313.95 M | |||
| Cash Per Share | 4.80 X | |||
| Total Debt | 143.23 M | |||
| Debt To Equity | 0.80 % | |||
| Current Ratio | 7.53 X | |||
| Book Value Per Share | 2.75 X | |||
| Cash Flow From Operations | (230.33 M) | |||
| Short Ratio | 0.99 X | |||
| Earnings Per Share | (4.49) X | |||
| Price To Earnings To Growth | (0.24) X | |||
| Number Of Employees | 339 | |||
| Beta | 1.74 | |||
| Market Capitalization | 2.26 B | |||
| Total Asset | 212.36 M | |||
| Retained Earnings | (743.75 M) | |||
| Working Capital | 192.36 M | |||
| Current Asset | 197.46 M | |||
| Current Liabilities | 5.1 M | |||
| Z Score | 1.5 |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Aimmune Therapeutics in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Aimmune Therapeutics' short interest history, or implied volatility extrapolated from Aimmune Therapeutics options trading.
Pair Trading with Aimmune Therapeutics
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Aimmune Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aimmune Therapeutics will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to Microsoft could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Microsoft when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Microsoft - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Microsoft to buy it.
The correlation of Microsoft is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Microsoft moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Microsoft moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Microsoft can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in population. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.
Other Consideration for investing in Aimmune Stock
If you are still planning to invest in Aimmune Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Aimmune Therapeutics' history and understand the potential risks before investing.
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities |